- Home
- / Amyris
Amyris
Total Funding
$551.9 M
Revenue
$269.8 M
FY, 2022
Amyris Summary
Company Summary
- Overview
- Amyris is a biotechnology research company that develops sustainable ingredients for the clean health and beauty markets. It offers a clean chemistry solution for engineering the genetics of yeast strains and fermenting them in sugarcane syrup.
- Type
- Private
- Status
- Active
- Founded
- 2003
- HQ
- Emeryville, CA, US | view all locations
- Website
- https://amyris.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Wojciech Adam Blaziak, Chief Manufacturing & Supply Chain Officer
Annie Tsong, Chief Strategy Officer & Product & Ingredients
Doris Choi, General Counsel & Secretary
LocationsView all
2 locations detected
Emeryville, CA HQ
United States
5885 Hollis Street, Suite 100
Sao Paulo, SP
Brazil
Rua John Dalton, 301 – Bloco B – Edificio 3 Condominio Techno Plaza
Amyris Financials
Summary Financials
- Revenue (Q1, 2023)
- $56.1M
- Gross profit (Q1, 2023)
- $5.0M
- Net income (Q1, 2023)
- ($201.8M)
- Cash (Q1, 2023)
- $11.2M
- EBIT (Q1, 2023)
- ($185.5M)